These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 16797728)

  • 1. Effects of IFN-beta, leptin and simvastatin on LIF secretion by T lymphocytes of MS patients and healthy controls.
    Vanderlocht J; Hendriks JJ; Venken K; Stinissen P; Hellings N
    J Neuroimmunol; 2006 Aug; 177(1-2):189-200. PubMed ID: 16797728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leukemia inhibitory factor is produced by myelin-reactive T cells from multiple sclerosis patients and protects against tumor necrosis factor-alpha-induced oligodendrocyte apoptosis.
    Vanderlocht J; Hellings N; Hendriks JJ; Vandenabeele F; Moreels M; Buntinx M; Hoekstra D; Antel JP; Stinissen P
    J Neurosci Res; 2006 Apr; 83(5):763-74. PubMed ID: 16477612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interferon-beta enhances monocyte and dendritic cell expression of B7-H1 (PD-L1), a strong inhibitor of autologous T-cell activation: relevance for the immune modulatory effect in multiple sclerosis.
    Schreiner B; Mitsdoerffer M; Kieseier BC; Chen L; Hartung HP; Weller M; Wiendl H
    J Neuroimmunol; 2004 Oct; 155(1-2):172-82. PubMed ID: 15342209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Time-dependent cytokine deviation toward the Th2 side in Japanese multiple sclerosis patients with interferon beta-1b.
    Ochi H; Feng-Jun M; Osoegawa M; Minohara M; Murai H; Taniwaki T; Kira J
    J Neurol Sci; 2004 Jul; 222(1-2):65-73. PubMed ID: 15240198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IFN-beta inhibits human Th17 cell differentiation.
    Ramgolam VS; Sha Y; Jin J; Zhang X; Markovic-Plese S
    J Immunol; 2009 Oct; 183(8):5418-27. PubMed ID: 19783688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monocyte-derived HLA-G acts as a strong inhibitor of autologous CD4 T cell activation and is upregulated by interferon-beta in vitro and in vivo: rationale for the therapy of multiple sclerosis.
    Mitsdoerffer M; Schreiner B; Kieseier BC; Neuhaus O; Dichgans J; Hartung HP; Weller M; Wiendl H
    J Neuroimmunol; 2005 Feb; 159(1-2):155-64. PubMed ID: 15652415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulatory effects of IFN-beta on production of osteopontin and IL-17 by CD4+ T Cells in MS.
    Chen M; Chen G; Nie H; Zhang X; Niu X; Zang YC; Skinner SM; Zhang JZ; Killian JM; Hong J
    Eur J Immunol; 2009 Sep; 39(9):2525-36. PubMed ID: 19670379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interferon-beta regulates cytokines and BDNF: greater effect in relapsing than in progressive multiple sclerosis.
    Hamamcioglu K; Reder AT
    Mult Scler; 2007 May; 13(4):459-70. PubMed ID: 17463069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of immunomodulatory treatment on leukocyte cytokine production in multiple sclerosis patients and healthy donors.
    Reske D; Thomas AV; Petereit HF; Fink GR; Schroeter M
    Neuroimmunomodulation; 2009; 16(6):385-91. PubMed ID: 19609087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abnormal B-cell cytokine responses a trigger of T-cell-mediated disease in MS?
    Bar-Or A; Fawaz L; Fan B; Darlington PJ; Rieger A; Ghorayeb C; Calabresi PA; Waubant E; Hauser SL; Zhang J; Smith CH
    Ann Neurol; 2010 Apr; 67(4):452-61. PubMed ID: 20437580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interferon-beta up-regulates the expression of co-stimulatory molecules CD80, CD86 and CD40 on monocytes: significance for treatment of multiple sclerosis.
    Marckmann S; Wiesemann E; Hilse R; Trebst C; Stangel M; Windhagen A
    Clin Exp Immunol; 2004 Dec; 138(3):499-506. PubMed ID: 15544628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term favorable response to interferon beta-1b is linked to cytokine deviation toward the Th2 and Tc2 sides in Japanese patients with multiple sclerosis.
    Mei FJ; Osoegawa M; Ochi H; Minohara M; Nan S; Murai H; Ishizu T; Taniwaki T; Kira J
    J Neurol Sci; 2006 Jul; 246(1-2):71-7. PubMed ID: 16581087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different effects of simvastatin and interferon beta on the proteolytic activity of matrix metalloproteinases.
    Kieseier BC; Archelos JJ; Hartung HP
    Arch Neurol; 2004 Jun; 61(6):929-32. PubMed ID: 15210533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreases in interleukin-4 secretion by invariant CD4(-)CD8(-)V alpha 24J alpha Q T cells in peripheral blood of patientswith relapsing-remitting multiple sclerosis.
    Gausling R; Trollmo C; Hafler DA
    Clin Immunol; 2001 Jan; 98(1):11-7. PubMed ID: 11141321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of the immunogenicity of different interferon beta-1a formulations using ex vivo T-cell assays.
    Jaber A; Baker M
    J Pharm Biomed Anal; 2007 Mar; 43(4):1256-61. PubMed ID: 17118612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the immunomodulatory effects of the plant sterol beta-sitosterol to simvastatin in peripheral blood cells from multiple sclerosis patients.
    Desai F; Ramanathan M; Fink CS; Wilding GE; Weinstock-Guttman B; Awad AB
    Int Immunopharmacol; 2009 Jan; 9(1):153-7. PubMed ID: 19022404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peripheral blood CD4+ T lymphocytes from multiple sclerosis patients are characterized by higher PSGL-1 expression and transmigration capacity across a human blood-brain barrier-derived endothelial cell line.
    Bahbouhi B; Berthelot L; Pettré S; Michel L; Wiertlewski S; Weksler B; Romero IA; Miller F; Couraud PO; Brouard S; Laplaud DA; Soulillou JP
    J Leukoc Biol; 2009 Nov; 86(5):1049-63. PubMed ID: 19696154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dysregulated neurotrophin mRNA production by immune cells of patients with relapsing remitting multiple sclerosis.
    Urshansky N; Mausner-Fainberg K; Auriel E; Regev K; Farhum F; Karni A
    J Neurol Sci; 2010 Aug; 295(1-2):31-7. PubMed ID: 20541775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interferon-gamma secretion by peripheral blood T-cell subsets in multiple sclerosis: correlation with disease phase and interferon-beta therapy.
    Becher B; Giacomini PS; Pelletier D; McCrea E; Prat A; Antel JP
    Ann Neurol; 1999 Feb; 45(2):247-50. PubMed ID: 9989628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expansion of CD4+CD28- T cells producing high levels of interferon-{gamma} in peripheral blood of patients with multiple sclerosis.
    Miyazaki Y; Iwabuchi K; Kikuchi S; Fukazawa T; Niino M; Hirotani M; Sasaki H; Onoé K
    Mult Scler; 2008 Sep; 14(8):1044-55. PubMed ID: 18573819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.